This is the banner text
AleraCare intends to double clinical capacity over the next 24-months to provide even greater support to its patients and providers
PHOENIX--(BUSINESS WIRE)--AleraCare, (the “Company”) a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations, today announced that it has launched a rebranding of the Company. The Company’s existing healthcare companies: MedicoRx Specialty Pharmacy, Vasco Infusion, VascoRx Specialty Pharmacy and Vasco Compounding have been consolidated under the AleraCare brand name.
As part of the rebranding, AleraCare has developed and introduced a new visual identity and a unified brand strategy to further support its core lines of business: ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. All of AleraCare’s existing treatment and service offerings will remain unchanged.
The unified brand enables AleraCare to provide a more cohesive and consistent experience for all existing and future patients as it grows its physical footprint, and advance physician-coordinated care standards through comprehensive and convenient infusion service offerings. Administered by best-in-class clinicians at convenient, accessible, patient-first locations, AleraCare will maintain trusted-partner status with physicians, payors and pharmaceutical manufacturer partners.
“Ensuring that we satisfy patients’ and physicians’ expectations by continuously improving our comprehensive care and optimizing outcomes in convenient facilities is paramount to fulfilling our vision of being recognized as a trusted partner and preferred destination for innovative, accessible, and revolutionary patient-focused site of care services,” said Russ Corvese, Chief Executive Officer of AleraCare. “Our clinical team members, facilities, and pharmaceutical partners all embrace and reflect this commitment. We are excited about AleraCare’s future and the next chapter of the Company’s growth.”
Founded in 2019, AleraCare has rapidly expanded to over 35 ambulatory infusion centers across the country. The company’s success to date has been achieved by being a provider-of-choice in infusion services and aims to be a nationally recognized leader, trusted partner, and preferred destination for innovative, accessible, and revolutionary patient-focused site of care services.
Members of AleraCare’s senior management team will be unveiling its new brand and vision during breakout sessions with pharma at the AXS23 Summit hosted by Asembia in Las Vegas, which is taking place from April 30 - May 4, 2023.
AleraCare is a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations. The company’s core lines of business include AleraCare advanced home infusion, AleraCare advanced specialty pharmacy and AleraCare advanced compounding pharmacy. AleraCare provides care to patients in over 35 locations across eight states throughout the United States, including Arizona, California, Colorado, Idaho, New Mexico, Oregon, Utah and Washington. For more information, please visit www.aleracare.com and follow the company on LinkedIn.
Media
Mike Geller
Prosek Partners
646-818-9018
mgeller@prosek.com
